Drug recall · February 14, 2018
Pantoprazole Sodium for Injection recall
Why: Presence of Particulate Matter: One vial from a lot of Pantoprazole Sodium for Injection (40 mg) contained a piece of glass
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Pantoprazole Sodium for Injection, 40 mg per vial, single dose vial, Rx only, Manufactured in India for: AuroMedics Pharma LLC, 6 Wheeling ROad, Dayton, NJ 08810. NDC 55150-202-00
- Lots / codes
Lot # CPO170035
- Quantity
- 66,100 vials
- Company
- AuroMedics Pharma LLC, East Windsor, NJ
- Distribution
- Product was distributed nationwide in the USA
- Initiated
- December 4, 2017 · Voluntary: Firm initiated
- Classified
- February 8, 2018
- Reported
- February 14, 2018
- Ended
- March 17, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Pantoprazole
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.